Orthofix Medical Delivering on Key Priorities to Start 2024

Orthofix Medical reported 1Q24 orthopedic sales of $188.6 million, up 7.7% compared to the first quarter of 2023.

Late last year, the company laid out its three strategic priorities for 2024: profitable growth, synergy across platforms and strategic innovation.

The organization started fast in the first quarter. Revenue from new...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us